Group A streptococcal infections. An old adversary reemerging with new tricks?
Feingold
D S
DS
Weinberg
A N
AN
D002981:Clindamycin / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D019115:Fasciitis, Necrotizing / Q000382:microbiology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D012772:Shock, Septic / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D013290:Streptococcal Infections / Q000453:epidemiology* / Q000382:microbiology / Q000628:therapy; D013297:Streptococcus pyogenes
D016756:Immunoglobulins, Intravenous; D010406:Penicillins; D002981:Clindamycin